Lara, P. N., Moon, J., Hesketh, P. J., Redman, M. W., Williamson, S. K., Akerley, W. L., . . . Gandara, D. R. (2015). SWOG 0709: Randomized Phase II Trial of Erlotinib vs. Erlotinib plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. J Thorac Oncol.

Lara, Primo N., James Moon, Paul J. Hesketh, Mary W. Redman, Stephen K. Williamson, Wallace L. Akerley, Fred R. Hirsch, Philip C. Mack, et David R. Gandara. "SWOG 0709: Randomized Phase II Trial of Erlotinib Vs. Erlotinib Plus Carboplatin/Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Impaired Performance Status As Selected By a Serum Proteomics Assay." J Thorac Oncol 2015.

Lara, Primo N., et al. "SWOG 0709: Randomized Phase II Trial of Erlotinib Vs. Erlotinib Plus Carboplatin/Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Impaired Performance Status As Selected By a Serum Proteomics Assay." J Thorac Oncol 2015.